"Our clinic serves both children and adults with neurological disorders. Our specialty is rare conditions, particularly those caused by genetic problems, and those that involve seizures. We offer a host of services from neurology clinic, to EEG, EKG, and EMG testing, as well as clinical research in new and emerging treatments. We take the time to get to know your family and understand your concerns so that we can find a way to help you or your child. In some cases that's finding a diagnosis for an undiagnosed condition. In others, it's finding the right treatment. In still others, it's connecting you with therapists, specialists, or family groups that can help you find what you need. In all cases it's about improving your quality of life."

During the past decade, Center for Rare Neurological Diseases conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Rare Neurological Diseases" #1 sponsor was "Takeda" with 3 trials, followed by "Center for Rare Neurological Diseases, Norcross, GA" with 1 trials sponsored, "Engage Therapeutics, Inc." with 1 trials sponsored, "Loulou Foundation" with 1 trials sponsored and "Marinus Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Rare Neurological Diseases" #1 collaborator was "Ovid Therapeutics Inc." with 2 trials as a collaborator, "Rett Syndrome Research Trust" with 1 trials as a collaborator and "Ultragenyx Pharmaceutical Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Center for Rare Neurological Diseases" are "Epilepsy" (5 trials), "15q Duplication Syndrome" (1 trials), "CDKL5 Deficiency Disease" (1 trials), "Cyclin-Dependent Kinase-Like 5 Deficiency Disorder" (1 trials) and "Dravet Syndrome" (1 trials). Many other conditions were trialed in "Center for Rare Neurological Diseases" in a lesser frequency.

Most popular intervention types in "Center for Rare Neurological Diseases" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Soticlestat" (2 trials), "Diazepam Nasal Spray [Valtoco]" (1 trials), "Ganaxolone" (1 trials) and "No intervention; observational" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Rare Neurological Diseases" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Center for Rare Neurological Diseases". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Center for Rare Neurological Diseases, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Rare Neurological Diseases, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".